As I’ve said elsewhere, the majority of the cost of developing a drug is from clinical trials, to make sure that the drug is safe and effective for human consumption. Unless we commoditize the medical services in US, this cost isn’t coming down. In fact, it’s going up.

Asking for lower price is simply asking for fewer whizzy new drugs. If our medical system price goes down, so will drug price.